Study Summary
This trial is testing whether two PET imaging agents can better predict tumor response and overall survival than MRI in patients with high-grade brain tumors.
- Brain Tumor
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 5 Secondary · Reporting Duration: 2 years
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
All Enrolled participants
1 of 1
Experimental Treatment
30 Total Participants · 1 Treatment Group
Primary Treatment: Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the total number of participants in this clinical research experiment?
"Affirmative. Records present on clinicaltrials.gov demonstrate that this medical trial is currently enlisting individuals; it was initially advertised in September 24th 2018, and the details were most recently updated October 6th 2022. The study demands 30 participants from a single location." - Anonymous Online Contributor
Are any new participants still eligible for this investigation?
"Yes, the current data on clinicaltrials.gov shows that this experiment is actively recruiting participants. It was initially posted in September 2018 and revised most recently in October 2022, with a need for 30 individuals across one medical centre." - Anonymous Online Contributor
Are there any records of experiments in which the imaging techniques [18F]FLT and [18F]Fluciclovine have been utilized together?
"At the moment, 4 active clinical trials are researching Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine with zero currently in Phase 3. These studies have been established across three different locations, one of which is Pittsburgh, Pennsylvania." - Anonymous Online Contributor
Is this the inaugural iteration of this particular clinical research?
"Since 2018, Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine have been investigated by Blue Earth Diagnostics. After the initial study with 30 participants in 2018, Phase 2 drug approval was granted for this product. Currently, there are 4 active studies on this topic taking place across 3 cities and 1 country." - Anonymous Online Contributor
Has the US Food and Drug Administration granted approval for Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine?
"Considering the lack of data validating its efficacy, Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine have been assigned a score of 2 on Power's safety scale." - Anonymous Online Contributor